Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2044 94 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Regeneron (REGN) is a biotech working in recombinant DNA technology. Until '94 it generally traded between 10 and 20 dollars until the FDA beat it up on it's treatment for Lou Gehrig's Disease. While it was trading at the $4 level at the end of '94, the former chairman of Merck(I believe) took the helm and the stock climbed back to about 11, then traded between 11 and 14. In late May, Option volume increased, news about a discovery concerning muscles was announced, and the stock has risen sharply to Friday, May 24 '96 close of 18.875.

Historically, the stock has failed around 22. Yet AMGEN has more than a 17.7% stake with warrants to increase it's stake to 20%, at 16$ per share. Could this be the time it breaks out?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2044Beginning of the end between Sanofi and REGN, or "end of beginning"?: Miljenko Zuanic-8 hours ago
2043Anyone with idea what is 'wrong" with REGN at this point of "SanofMiljenko Zuanic-last Thursday
2042Damage to Praluent is already done and will increase in coming months. But, therMiljenko Zuanic-February 9
2041While overturning is certainly good news, I can't imagine given the uncertaiFelix B-February 9
2040That was time-point when injunction was to start, which was overturned yesterdayMiljenko Zuanic-February 9
2039You said in earlier thread appeal decision was 45 days from Jan 5 or was that inFelix B-February 9
2038For now Praluent stay on market. Zuanic-February 8
2037Ok—we're on the same wavelength.DewDiligence_on_SI-February 3
2036I did not say "impressive", I said "only" positive. I do agrMiljenko Zuanic-February 3
203522% RRR (if that's what is turns out to be) is a meh result, IMO, insofar asDewDiligence_on_SI-February 3
2034Dos REGN222 (anti-RSV Ab) have future? fiercebiotech.comMiljenko Zuanic-February 3
2033It is 50 : 50, or less. )-:Miljenko Zuanic-February 3
2032I really hope REGN isn't pulled off market...Felix B-February 2
2031Repatha score positive, how well ..until 3-17? PS: To considMiljenko Zuanic-February 2
2030Roche is reporting CHF329m ($332m) Lucentis 4Q sale (ver. $376 for 3Q) which is Miljenko Zuanic-February 1
2029Spay is a "spay", nothing more...nothing less.Miljenko Zuanic-January 31
2028 Tony Coles joins REGN BOD. "Dr. Coles was nominatBiotech Jim-January 31
2027RTH258 stuff (probably old hat for readers of this board): siliconinvestor.comDewDiligence_on_SI-January 29
2026And they also reported OMER holdings. They (BR) are voting with $$ in this sectBiotech Jim-January 26
2025Sorry for confusion, it is not...they increased holding in BIIB, AMGN, and GILDMiljenko Zuanic-January 25
2024Just to make it clear, their cumulative (based on 6.1 m shares) confidence is hiMiljenko Zuanic-January 25
20236.1 m from 2.3 (3Q-16), that is $~1.4 B confidence! WOWMiljenko Zuanic-January 25
2022Blackrock likes the stock, 5.9% ownership. investor.regeneron.comBiotech Jim-January 25
2021Yes, Roche increase rebate in US, and Novartis in ex-US, in 4Q, to better competMiljenko Zuanic-January 25
2020Ex-US Lucentis had slightly negative QoQ pricing with positive volume growth, acDewDiligence_on_SI-January 25
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.